Theravance Biopharma, Inc. (TBPH)
17.01
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
17.00
-0.01
(-0.06%)
After-Hours: 20:00
Theravance Biopharma Total Liabilities (Quarterly) : 180.06M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 180.06M |
| March 31, 2026 | 181.72M |
| December 31, 2025 | 188.85M |
| September 30, 2025 | 182.78M |
| June 30, 2025 | 201.19M |
| March 31, 2025 | 177.60M |
| December 31, 2024 | 178.62M |
| September 30, 2024 | 170.45M |
| June 30, 2024 | 168.34M |
| March 31, 2024 | 166.44M |
| December 31, 2023 | 169.00M |
| September 30, 2023 | 167.46M |
| June 30, 2023 | 166.47M |
| March 31, 2023 | 167.99M |
| December 31, 2022 | 165.60M |
| September 30, 2022 | 282.92M |
| June 30, 2022 | 710.57M |
| March 31, 2022 | 706.81M |
| December 31, 2021 | 713.39M |
| September 30, 2021 | 726.70M |
| June 30, 2021 | 729.62M |
| March 31, 2021 | 748.33M |
| December 31, 2020 | 772.81M |
| September 30, 2020 | 773.72M |
| June 30, 2020 | 766.67M |
| Date | Value |
|---|---|
| March 31, 2020 | 763.34M |
| December 31, 2019 | 632.67M |
| September 30, 2019 | 628.14M |
| June 30, 2019 | 629.67M |
| March 31, 2019 | 644.52M |
| December 31, 2018 | 611.82M |
| September 30, 2018 | 384.41M |
| June 30, 2018 | 386.98M |
| March 31, 2018 | 416.70M |
| December 31, 2017 | 326.22M |
| September 30, 2017 | 302.04M |
| June 30, 2017 | 302.76M |
| March 31, 2017 | 294.09M |
| December 31, 2016 | 289.02M |
| September 30, 2016 | 58.42M |
| June 30, 2016 | 52.90M |
| March 31, 2016 | 54.59M |
| December 31, 2015 | 57.05M |
| September 30, 2015 | 34.96M |
| June 30, 2015 | 31.80M |
| March 31, 2015 | 35.79M |
| December 31, 2014 | 47.98M |
| September 30, 2014 | 41.88M |
| June 30, 2014 | 45.83M |
| March 31, 2014 | 44.08M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Zymeworks, Inc. | 316.60M |
| Viatris, Inc. | 20.78B |
| Ocular Therapeutix, Inc. | 151.28M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 469.77M |
| Shareholders Equity (Quarterly) | 289.70M |
| Debt to Equity Ratio | 0.2463 |
| Current Ratio | 13.54 |
| Net Debt Paydown Yield | 0.18% |